Skip to content

Evaluation of diagnostic hysteroscopy findings in patients candidate ART (IVF, ICSI )

Evaluation of diagnostic hysteroscopy findings in patients candidate for ART (IVF, ICSI ) and its effect on pregnancy rate Compared to control group.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201208152565N6
Enrollment
100
Registered
2012-10-08
Start date
2012-06-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Infertility. Female infertility of uterine origin

Interventions

Intervention 1: Control Group:Hysterodcopy is not done. Intervention 2: In the case groupHysteroscopy is performed , submucosal myoma or polyps 1 cm or larger cervical or uterine adhesions within C
Treatment - Devices
Treatment - Other
Control Group:Hysterodcopy is not done
In the case groupHysteroscopy is performed , submucosal myoma or polyps 1 cm or larger cervical or uterine adhesions within Chonnell ,with hysteroscopy will be resolved , If this is not possible w

Sponsors

Research Council of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: inclusion Criteria:Hysterosalpingography normal during the past 12 month;Normal vaginal ultrasound TVS;Age between 25-40 year;The absence of abnormal uterine bleeding (AUB) and lack of hysteroscopy performed in the last 6 months. Exclusion Criteria:Abnormal uterine bleeding; hysteroscopy performed in the last 6 months;Abnormal Vaginal Ultrasound .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pathologic findings on hysteroscopy. Timepoint: During the hysterectomy. Method of measurement: View the eyes and Biopsy.;Polip. Timepoint: During the hysteroscopy. Method of measurement: View the eyes and Biopsy.;Adhesion. Timepoint: During the hysteroscopy. Method of measurement: View the eyes and Biopsy.;Fibroma. Timepoint: During the hysteroscopy. Method of measurement: View the eyes and Biopsy.

Secondary

MeasureTime frame
Impact on IVF outcomes. Timepoint: 14 days after embryo transfer. Method of measurement: Blood Tests.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Sohrabvand

Vali-e-Asr reproductive HealthnResearch center

fsohrabvand@yahoo.com+98 21 6693 9320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026